The circa of aminogli (3, 4, 7) . A has recentl such as lo, (2, 5 fever, no information is available on the circadian and every 24 h after. After the urine volumes were meanephrotoxicity induced by ISP. The present sured, urine samples were centrifuged at 3,000 rpm for 10 was conducted to determine the influence of a min. N-Acetyl-3-D-glucosaminidase (NAG) activity was tage-dependent dosing schedule on the nephromeasured in the supernatant and expressed as international ISP and to investigate the relationship between units per total urine collected for 24 h. Blood samples were y and the chronopharmacokinetics of the drug in obtained from the inferior vena cava, and kidney samples were taken for the determination of ISP concentrations in star rats (5 weeks old, weighing 160 to 170 g) were the plasma and kidney. ISP levels in plasma and kidney were were housed in a light-controlled room (lights on determined by fluorescence polarization immunoassay a.m. to 7:00 p.m.) at a room temperature of 24 + (TDX; Dinabot, Ltd., Tokyo, Japan). Kidney samples were amidity of 60% + 10%, with food and water ad then prepared for histopathological observations by standard e rats were randomly assigned to seven groups of periodic acid-Schiff staining. Histopathological sections of ach and were housed individually in metabolic kidney were evaluated independently by a pathologist who fllect urine. Groups of 35 rats each were given ISP was unaware of the regimens used. Although urine volume is known to increase significantly during the day and decrease during the night among day-/24h) active individuals, there were no significant differences in 24-h urinary volumes for the various groups. Urinary NAG activity in animals dosed only at midlight or twice daily remained low for 7 days, rose abruptly to a peak at 11 days, and fell rapidly to baseline by 14 days. In contrast, in animals /t dosed only at middark, urinary NAG levels remained low for /S & '% 9 days and the rise after that was more gradual (P < 0.05 by /, ĨStudent's t test) and without a decline through 14 days (Fig.   1 ). Renal tissue specimens were examined histologically. Rats given ISP at midlight or by twice-daily dosing showed tubular necrosis. Following middark dosing, the pathological abnormalities were significantly reduced ( Table 1) .
Levels of ISP in both kidney and plasma were significantly 1 1 3 5 7 9 1 1 13 reduced following middark dosing compared with those of Time a ft e r administration ( days ) midlight dosing or twice-daily dosing ( Fig. 2 and 3) .
Nephrotoxicity was more marked in rats receiving ISP at rime course of urinary NAG~activity in rats after adminmidlight than at middark, and the once-daily administration [SP by once-daily subcutaneous inJection of 300 mg/kg at milih tha atmdak'n h nediyamnsrto ) or at midlight (P) and by twice-daily injection of 150 at middark induced a lesser degree of nephrotoxicity than or 15 consecutive days. Each point represents the mean the twice-daily inJections, which indicates that the oncedeviation) for five rats.
daily treatment therapy has a potential value in the clinical use of aminoglycosides (2) . A similar significant circadian onding author. change was shown for plasma and kidney ISP concentrations a circadian-stage-dependent dosing schedule has a significant influence on the nephrotoxicity of ISP in rats.
Since the pharmacokinetics of aminoglycosides are very much influenced by nephrotoxicity, because they are renally excreted, toxicity may depend on kinetics.
Since pharmacokinetics may affect efficacy, one might wonder whether the lower peak plasma levels with middark dosing might be associated with less rapid killing of bacteria and shorter postantibiotic effect, both of which might have a negative impact on efficacy. The significant circadian-stagedependent changes in ISP kinetics were demonstrated by the lower clearance, the longer half-life, and the larger area under the curve in evening trials with humans (6).
Therefore, the dosing schedule and the choice of the most appropriate time of day for drug administration may help to achieve rational chronotherapeutics, reducing toxic effects of ISP and/or increasing therapeutic effects.
